• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

射血分数保留的原发性心力衰竭:一些最相关表型的相互交织的病理生理学与治疗

Primary heart failure with preserved ejection fraction: The intertwined pathophysiology and treatment of some of the most relevant phenotypes.

作者信息

Ono Ryohei, Menezes Falcão Luiz

机构信息

Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba Japan.

Academic Medical Center of Lisbon (CAML), Cardiovascular Center of the University of Lisbon (CCUL@RISE), Faculty of Medicine of the University of Lisbon, Lisbon, Portugal.

出版信息

Rev Port Cardiol. 2025 Jul;44(7):445-456. doi: 10.1016/j.repc.2025.02.007. Epub 2025 Jun 3.

DOI:10.1016/j.repc.2025.02.007
PMID:40472932
Abstract

Heart failure with preserved ejection fraction (HFpEF) is characterized by diverse underlying pathophysiological mechanisms and can be divided into two subgroups based on the identification of the specific cause: primary and secondary HFpEF. Primary HFpEF is caused by primary impairments in myocardial relaxation or compliance with the contribution of several risk factors. Therefore, we have reviewed current literature on pathophysiology and treatment in patients with primary HFpEF. Patients with primary HFpEF represent specific "phenotypes" and are usually elderly, more commonly women, and often with a history of arterial hypertension, obesity, iron deficiency (ID), coronary artery disease (CAD), sleep apnea, diabetes, chronic kidney disease (CKD), and chronotropic incompetence. Some of the main pathophysiological mechanisms for each phenotype of primary HFpEF are as follows: arterial hypertension, which promotes left ventricular hypertrophy and fibrosis; obesity, which contributes through systemic inflammation and metabolic dysregulation; aging, which leads to ventricular-vascular stiffening; gender differences, with women experiencing changes due to smaller heart size and hormonal shifts; ID, which affects mitochondrial function; CAD, which impairs myocardial blood flow; diabetes, which is associated with hyperglycemia, lipotoxicity, insulin resistance, and microvascular rarefaction; CKD, which leads to hypertension, metabolic disturbance, systemic inflammation, and endothelial dysfunction; sleep apnea, which induces cardiac changes through pressure swings and hypoxia; and chronotropic incompetence, which is due to reduced cardiac β-receptor responsiveness. In conclusion, each factor intricately contributes to the complex pathophysiology of HFpEF. Understanding these interrelated mechanisms is critical for tailoring management strategies to improve outcomes in HFpEF patients.

摘要

射血分数保留的心力衰竭(HFpEF)具有多种潜在的病理生理机制,根据特定病因可分为两个亚组:原发性和继发性HFpEF。原发性HFpEF由心肌舒张或顺应性的原发性损害以及多种危险因素共同作用引起。因此,我们回顾了目前关于原发性HFpEF患者病理生理学和治疗的文献。原发性HFpEF患者具有特定的“表型”,通常为老年人,女性更为常见,且常伴有动脉高血压、肥胖、缺铁(ID)、冠状动脉疾病(CAD)、睡眠呼吸暂停、糖尿病、慢性肾脏病(CKD)和变时性功能不全病史。原发性HFpEF各表型的一些主要病理生理机制如下:动脉高血压促进左心室肥厚和纤维化;肥胖通过全身炎症和代谢失调起作用;衰老导致心室-血管僵硬;性别差异,女性因心脏较小和激素变化而出现改变;缺铁影响线粒体功能;CAD损害心肌血流;糖尿病与高血糖、脂毒性、胰岛素抵抗和微血管稀疏有关;CKD导致高血压、代谢紊乱、全身炎症和内皮功能障碍;睡眠呼吸暂停通过压力波动和缺氧引起心脏变化;变时性功能不全是由于心脏β受体反应性降低。总之,每个因素都错综复杂地促成了HFpEF复杂的病理生理学。了解这些相互关联的机制对于制定管理策略以改善HFpEF患者的预后至关重要。

相似文献

1
Primary heart failure with preserved ejection fraction: The intertwined pathophysiology and treatment of some of the most relevant phenotypes.射血分数保留的原发性心力衰竭:一些最相关表型的相互交织的病理生理学与治疗
Rev Port Cardiol. 2025 Jul;44(7):445-456. doi: 10.1016/j.repc.2025.02.007. Epub 2025 Jun 3.
2
Sex-specific cardiometabolic multimorbidity, metabolic syndrome and left ventricular function in heart failure with preserved ejection fraction in the UK Biobank.英国生物银行中射血分数保留的心力衰竭患者的性别特异性心脏代谢多重疾病、代谢综合征与左心室功能
Cardiovasc Diabetol. 2025 Jun 4;24(1):238. doi: 10.1186/s12933-025-02788-4.
3
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
4
Interplay of Chronic Kidney Disease and the Effects of Tirzepatide in Patients With Heart Failure, Preserved Ejection Fraction, and Obesity: The SUMMIT Trial.慢性肾脏病与替尔泊肽对射血分数保留的肥胖心力衰竭患者的影响:SUMMIT试验
J Am Coll Cardiol. 2025 May 13;85(18):1721-1735. doi: 10.1016/j.jacc.2025.03.009. Epub 2025 Mar 31.
5
Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.用于射血分数保留的慢性心力衰竭的β受体阻滞剂和肾素-血管紧张素-醛固酮系统抑制剂。
Cochrane Database Syst Rev. 2018 Jun 28;6(6):CD012721. doi: 10.1002/14651858.CD012721.pub2.
6
Ventilator Management呼吸机管理
7
Computational investigation of the role of ventricular remodelling in HFpEF: The key to phenotype dissection.计算研究心室重构在 HFpEF 中的作用:表型分析的关键。
Comput Biol Med. 2024 Sep;180:109019. doi: 10.1016/j.compbiomed.2024.109019. Epub 2024 Aug 16.
8
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
9
Systemic Inflammatory Response Syndrome全身炎症反应综合征
10
The importance of integrated left atrial evaluation: From hypertension to heart failure with preserved ejection fraction.综合左心房评估的重要性:从高血压到射血分数保留的心力衰竭。
Int J Clin Pract. 2018 Feb;72(2). doi: 10.1111/ijcp.13050. Epub 2017 Dec 28.